110 likes | 129 Views
Global Bone Cancer Diagnosis and Therapeutics Market Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023
E N D
Orion Market Research GLOBAL BONE CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND FORECAST 2018-2023
DEFINITION The global bone cancer diagnosis and therapeutics market is anticipated to grow at a CAGR of 7.8% by 2023. Several factors such as exposure towards radiation, factures, treatment for certain cancer related drugs, and genetic disorders cause bone cancer.
MARKET MOTIVATORS • Robust healthcare expenditure in the • developed economies • Exposure towards radioactive material • Rising geriatric population • Increasing incidence of paget diseases • among individuals • Stem cell transplants technology
MARKET RESTRAINTS • Lack of awareness towards diagnosis and • therapeutics in developing and under • developed nations • High cost of treatment
MARKET SEGMENTATION • BY TYPE • Primary bone cancer • Secondary bone cancer
MARKET SEGMENTATION • BY DIAGNOSIS • Mri scans • X-rays • Ct-scan • Radionuclide bone sensors • Biopsy • Others
MARKET PLAYERS • Ablynz • Allergan • Aveo Pharmaceuticals, Inc. • Amgen Inc. • Amura Holdings Ltd. • Bayer AG • Catena Pharmaceuticals Inc. • Celldex Therapeutics • To Be Continued……
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 +91-7803040404 +1-6467557667 info@omrglobal.com www.omrglobal.com https://www.omrglobal.com/industry-reports/bone-cancer-diagnosis-and-therapeutics-market/